In other words, the amount of sIL-6R was lower compared to sgp130 in SLE and IgA patients, though we could consider the simultaneous activation of the two IL-6-mediated signaling pathways in SLE and IgA nephropathy. This evidence concerns the gene IL6ST and systemic lupus erythematosus.